156
Views
56
CrossRef citations to date
0
Altmetric
Original Research

LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression

, &
Pages 7307-7315 | Published online: 02 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhixing Xu, Haitao Xu, Xi Chen, Xiaobing Huang, Jintao Tian, Jinxi Zhao, Bohu Liu, Fengcai Shi, Jin Wu & Jun Pu. (2023) CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma. OncoTargets and Therapy 16, pages 819-837.
Read now
Jayashree V. Raghavan, Raksha A. Ganesh, Pranali Sonpatki, Divya Naik, Arivusudar Everad John, Priyanka Arunachalam, Darshat Shah, Hari P. S.Akhila Lakshmikantha, Shibu Pillai, Komal Prasad Chandrachari, Kiran Mariswamappa, Sathyanarayana Lale, Nameeta Shah & Siddharth Jhunjhunwala. (2021) Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin. OncoImmunology 10:1.
Read now

Articles from other publishers (54)

Juan Wang, Ning Zhang, Xiuping Ding, Chengrui Fu, Xiaodong Li, Baosheng Li, Jianxun Ding & Tianmeng Sun. (2024) Targeted nanostrategies eliminate pre-metastatic niche of cancer. Nano Research.
Crossref
Francesca Pettinella, Barbara Mariotti, Chiara Lattanzi, Kirsten Bruderek, Marta Donini, Sara Costa, Olivia Marini, Giulia Iannoto, Sara Gasperini, Elena Caveggion, Monica Castellucci, Federica Calzetti, Francisco Bianchetto-Aguilera, Elisa Gardiman, Matteo Giani, Stefano Dusi, Maurizio Cantini, Aurora Vassanelli, Denise Pavone, Michele Milella, Sara Pilotto, Pamela Biondani, Benedikt Höing, Marie Carolin Schleupner, Timon Hussain, Boris Hadaschik, Cordelia Kaspar, Carlo Visco, Cristina Tecchio, Leo Koenderman, Flavia Bazzoni, Nicola Tamassia, Sven Brandau, Marco A. Cassatella & Patrizia Scapini. (2024) Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors. Cell Reports Medicine 5:2, pages 101380.
Crossref
Benjamin A. Kansy, Tim P. Wehrs, Kirsten Bruderek, Yu Si, Sonja Ludwig, Freya Droege, Pia Hasskamp, Uta Henkel, Nina Dominas, Thomas K. Hoffmann, Peter A. Horn, Martin Schuler, Thomas C. Gauler, Monika Lindemann, Stephan Lang, Agnes Bankfalvi & Sven Brandau. (2023) HPV-associated head and neck cancer is characterized by distinct profiles of CD8+ T cells and myeloid-derived suppressor cells. Cancer Immunology, Immunotherapy 72:12, pages 4367-4383.
Crossref
Lei Wu, Yuantong Liu, Weiwei Deng, Tianfu Wu, Linlin Bu & Lei Chen. (2023) OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC. International Journal of Molecular Sciences 24:16, pages 12904.
Crossref
K. Ina Ly, Leland G. Richardson, Mofei Liu, Alona Muzikansky, Jonathan Cardona, Kevin Lou, Andrew L. Beers, Ken Chang, James M. Brown, Xiaoyue Ma, David A. Reardon, Isabel C. Arrillaga-Romany, Deborah A. Forst, Justin T. Jordan, Eudocia Q. Lee, Jorg Dietrich, Lakshmi Nayak, Patrick Y. Wen, Ugonma Chukwueke, Anita Giobbie-Hurder, Bryan D. Choi, Tracy T. Batchelor, Jayashree Kalpathy-Cramer, William T. Curry & Elizabeth R. Gerstner. (2023) Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients. Clinical Cancer Research 29:16, pages 3017-3025.
Crossref
Soumaya Rafii, Sarah Kandoussi, Amina Ghouzlani, Oumayma Naji, Konala Priyanka Reddy, Rizwan Ullah Sadiqi & Abdallah Badou. (2023) Deciphering immune microenvironment and cell evasion mechanisms in human gliomas. Frontiers in Oncology 13.
Crossref
Vaishali Bhardwaj & Stephen M. Ansell. (2023) Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies. Frontiers in Cell and Developmental Biology 11.
Crossref
Tao Zhang, Ying He, Gene Chi Wai Man, Yang Ding, Chi Chiu Wang & Jacqueline Pui Wah Chung. 2023. Myeloid-derived suppressor cells. Myeloid-derived suppressor cells 191 220 .
Dandan Xu, Cheng Li, Yushan Xu, Mingyue Huang, Dawei Cui & Jue Xie. (2022) Myeloid-derived suppressor cell: A crucial player in autoimmune diseases. Frontiers in Immunology 13.
Crossref
Xuehua Zhang, Leilei Zhao, He Zhang, Yurui Zhang, Huanyu Ju, Xiaoyu Wang, Huan Ren, Xiao Zhu & Yucui Dong. (2022) The immunosuppressive microenvironment and immunotherapy in human glioblastoma. Frontiers in Immunology 13.
Crossref
Eun Jung Lee, Seungpil Jung, Kyong Hwa Park & Serk In Park. (2022) Flow cytometry-based immunophenotyping of myeloid-derived suppressor cells in human breast cancer patient blood samples. Journal of Immunological Methods 510, pages 113348.
Crossref
Yuan-yuan Wang, Shuang-ying Li, San-qian Chen, Liang-liang Wang & Zhi-qiang Han. (2022) Myeloid-derived Suppressor Cells Activate Liver Natural Killer Cells in a Murine Model in Uveal Melanoma. Current Medical Science 42:5, pages 1071-1078.
Crossref
Ming Zhang, Tingju Wei, Xiaodan Zhang & Danfeng Guo. (2022) Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy. Frontiers in Immunology 13.
Crossref
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, Ilaria Grazia Zizzari, Luca D’Angelo, Antonio Santoro, Marianna Nuti, Hassan Rahimi & Aurelia Rughetti. (2022) Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma. International Journal of Molecular Sciences 23:11, pages 6312.
Crossref
Muhan Li, Runfeng Zhang, Ji Li & Jingnan Li. (2022) The Role of C-Type Lectin Receptor Signaling in the Intestinal Microbiota-Inflammation-Cancer Axis. Frontiers in Immunology 13.
Crossref
Lily Chan, Solmaz Morovati, Negar Karimi, Kasra Alizadeh, Sierra Vanderkamp, Julia E. Kakish, Byram W. Bridle & Khalil Karimi. (2022) Neutrophil Functional Heterogeneity and Implications for Viral Infections and Treatments. Cells 11:8, pages 1322.
Crossref
Nesrine Mabrouk, Baptiste Lecoeur, Ali Bettaieb, Catherine Paul & Frédérique Végran. (2022) Impact of Lipid Metabolism on Antitumor Immune Response. Cancers 14:7, pages 1850.
Crossref
Brian S. M. Munansangu, Colin Kenyon, Gerhard Walzl, André G. Loxton, Leigh A. Kotze & Nelita du Plessis. (2022) Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for Mycobacterium tuberculosis Infection and Insights from Tumor Biology. International Journal of Molecular Sciences 23:7, pages 3512.
Crossref
Elena Codrici, Ionela-Daniela Popescu, Cristiana Tanase & Ana-Maria Enciu. (2022) Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment. International Journal of Molecular Sciences 23:5, pages 2509.
Crossref
Kristin C. Hicks, Yulia Y. Tyurina, Valerian E. Kagan & Dmitry I. Gabrilovich. (2022) Myeloid Cell–Derived Oxidized Lipids and Regulation of the Tumor Microenvironment. Cancer Research 82:2, pages 187-194.
Crossref
Ajay Dixit & Mahendra Singh. 2022. Immuno-Oncology Crosstalk and Metabolism. Immuno-Oncology Crosstalk and Metabolism 1 20 .
Defne Bayik, Juyeun Lee & Justin D. Lathia. 2022. Interaction of Immune and Cancer Cells. Interaction of Immune and Cancer Cells 189 217 .
Valquiria Bueno & Graham Pawelec. 2022. Healthy Longevity and Immune System. Healthy Longevity and Immune System 53 64 .
Jianying Li, Chelsea Bolyard, Gang Xin & Zihai Li. (2021) Targeting Metabolic Pathways of Myeloid Cells Improves Cancer Immunotherapy. Frontiers in Cell and Developmental Biology 9.
Crossref
Mengting Zhu, Yuping Xu, Caihua Li, Zhimin Lu, Kaihuan Bi, Kangxia Wang, Peipei Guo, Huanhuan Jiang & Yunxia Cao. (2021) Involvement of impaired CD8+ mucosal-associated invariant T cells and myeloid-derived suppressor cells in polycystic ovary syndrome. Reproductive Biology and Endocrinology 19:1.
Crossref
M. Murdocca, C. De Masi, S. Pucci, R. Mango, G. Novelli, C. Di Natale & F. Sangiuolo. (2021) LOX-1 and cancer: an indissoluble liaison. Cancer Gene Therapy 28:10-11, pages 1088-1098.
Crossref
Melissa S. F. Ng, Leonard Tan, Quanbo Wang, Charles R. Mackay & Lai Guan Ng. (2021) Neutrophils in cancer—unresolved questions. Science China Life Sciences 64:11, pages 1829-1841.
Crossref
Christopher Groth, Rebekka Weber, Samantha Lasser, Feyza Gül Özbay, Annina Kurzay, Vera Petrova, Peter Altevogt, Jochen Utikal & Viktor Umansky. (2021) Tumor promoting capacity of polymorphonuclear myeloid‐derived suppressor cells and their neutralization. International Journal of Cancer 149:9, pages 1628-1638.
Crossref
Benjamin T. Himes, Philipp A. Geiger, Katayoun Ayasoufi, Adip G. Bhargav, Desmond A. Brown & Ian F. Parney. (2021) Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications. Frontiers in Oncology 11.
Crossref
Zengpanpan Ye, Xiaolin Ai, Linjie Zhao, Fan Fei, Ping Wang & Shengtao Zhou. (2021) Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics. Oncogene 40:42, pages 6059-6070.
Crossref
Francesca Hofer, Gianna Di Sario, Chiara Musiu, Silvia Sartoris, Francesco De Sanctis & Stefano Ugel. (2021) A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment. Cells 10:10, pages 2700.
Crossref
Merav E. Shaul & Zvi G. Fridlender. (2021) The dual role of neutrophils in cancer. Seminars in Immunology 57, pages 101582.
Crossref
Dan Li, Li Lu, Wei Kong, Xiaoyu Xia, Yuchen Pan, Jingman Li, Jiali Wang, Tingting Wang, Jun Liang, Huan Dou & Yayi Hou. (2021) C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1+ M-MDSCs in relieving lupus-like symptoms. Cell Death & Disease 12:9.
Crossref
Iosif Papafragkos, Efrosyni Markaki, Christina Kalpadakis & Panayotis Verginis. (2021) Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies. Journal of Clinical Medicine 10:16, pages 3462.
Crossref
Xinyu Tian, Ting Wang, Qisi Zheng, Yue Tao, Lei Dai & Han Shen. (2021) Circulating CD15 + LOX‐1 + PMN‐MDSCs are a potential biomarker for the early diagnosis of non‐small‐cell lung cancer . International Journal of Clinical Practice 75:8.
Crossref
Filippo Veglia, Emilio Sanseviero & Dmitry I. Gabrilovich. (2021) Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nature Reviews Immunology 21:8, pages 485-498.
Crossref
Houhui Shi, Kai Li, Yanghong Ni, Xiao Liang & Xia Zhao. (2021) Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy. Frontiers in Cell and Developmental Biology 9.
Crossref
Yogesh R. Suryawanshi & Autumn J. Schulze. (2021) Oncolytic Viruses for Malignant Glioma: On the Verge of Success?. Viruses 13:7, pages 1294.
Crossref
Xuyan Pan, Zhaopeng Wang, Fang Liu, Feihui Zou, Qijun Xie, Yizhuo Guo & Liang Shen. (2021) A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas. Translational Oncology 14:7, pages 101109.
Crossref
Kathryn E. Cole, Quan P. Ly, Michael A. Hollingsworth, Jesse L. Cox, James C. Padussis, Jason M. Foster, Luciano M. Vargas & James E. Talmadge. (2021) Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis. Cellular Immunology 363, pages 104317.
Crossref
Vera M. Kho, Vera E. Mekers, Paul N. Span, Johan Bussink & Gosse J. Adema. (2021) Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment. Cellular Immunology 362, pages 104298.
Crossref
Françoise Gondois-Rey, Magali Paul, Florence Alcaraz, Sarah Bourass, Jilliana Monnier, Nausicaa Malissen, Jean-Jacques Grob, Annika M. Bruger, Pierre Van Der Bruggen, Caroline Gaudy-Marqueste & Daniel Olive. (2021) Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma. Cancers 13:6, pages 1362.
Crossref
Nicola Tumino, Anna Laura Di Pace, Francesca Besi, Linda Quatrini, Paola Vacca & Lorenzo Moretta. (2021) Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT. Frontiers in Immunology 12.
Crossref
Yongtong Ge, Dalei Cheng, Qingzhi Jia, Huabao Xiong & Junfeng Zhang. (2021) Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad. Immune Network 21:3.
Crossref
Matthew M. Grabowski, Eric W. Sankey, Katherine J. Ryan, Pakawat Chongsathidkiet, Selena J. Lorrey, Daniel S. Wilkinson & Peter E. Fecci. (2020) Immune suppression in gliomas. Journal of Neuro-Oncology 151:1, pages 3-12.
Crossref
Antonis Stylianos Papaioannou, Athina Boumpas, Miranta Papadopoulou, Aikaterini Hatzioannou, Themis Alissafi & Panayotis Verginis. 2021. Myeloid-Derived Suppressor Cells. Myeloid-Derived Suppressor Cells 85 98 .
Leigh A. Kotze, Vinzeigh N. Leukes & Nelita Du Plessis. 2021. Myeloid-Derived Suppressor Cells. Myeloid-Derived Suppressor Cells 129 156 .
Alessandra De Leo, Alessio Ugolini & Filippo Veglia. (2020) Myeloid Cells in Glioblastoma Microenvironment. Cells 10:1, pages 18.
Crossref
Elliot D. Kramer & Scott I. Abrams. (2020) Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity. Frontiers in Immunology 11.
Crossref
Anca Dorhoi, Leigh A. Kotzé, Jay A. Berzofsky, Yongjun Sui, Dmitry I. Gabrilovich, Ankita Garg, Richard Hafner, Shabaana A. Khader, Ulrich E. Schaible, Stefan H.E. Kaufmann, Gerhard Walzl, Manfred B. Lutz, Robert N. Mahon, Suzanne Ostrand-Rosenberg, William Bishai & Nelita du Plessis. (2020) Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus. Journal of Clinical Investigation 130:6, pages 2789-2799.
Crossref
Tomasz M. Grzywa, Anna Sosnowska, Paweł Matryba, Zuzanna Rydzynska, Marcin Jasinski, Dominika Nowis & Jakub Golab. (2020) Myeloid Cell-Derived Arginase in Cancer Immune Response. Frontiers in Immunology 11.
Crossref
Valentina Bruno, Giacomo Corrado, Denisa Baci, Benito Chiofalo, Maria Antonia Carosi, Livia Ronchetti, Emilio Piccione, Adriana Albini, Douglas M. Noonan, Giulia Piaggio & Enrico Vizza. (2020) Endometrial Cancer Immune Escape Mechanisms: Let Us Learn From the Fetal–Maternal Interface. Frontiers in Oncology 10.
Crossref
Caroline Bergenfelz & Karin Leandersson. (2020) The Generation and Identity of Human Myeloid-Derived Suppressor Cells. Frontiers in Oncology 10.
Crossref
Carlos Del Fresno, Francisco J. Cueto & David Sancho. 2020. C-Type Lectins in Immune Homeostasis. C-Type Lectins in Immune Homeostasis 117 145 .